Tridek-One
Latest round
- Series A
Last raised
- Nov 2018
Total raised
- $3.4M
Investors
- 2
About Tridek-One
Based in Paris, France, and founded in 2018, Tridek-One SAS is a biotechnology startup focused on the research and development of CD31 agonist molecules, intended for restoring the immune balance in patients suffering from auto-immune diseases. Tridek-One SAS develops novel CD31 (also known as PECAM-1) checkpoint agonists that are capable of restoring the inhibitory activity of CD31 in immune and endothelial cells, by targeting activated cells and exerting a regulatory effect. The CD31 agonist molecules can rebalance the immune system without immunosuppression, which makes it a potential target for autoimmune and inflammatory disorders.
Who invested in Tridek-One
2 investors across 1 round
See all investors in Tridek-One
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 26, 2018
Amount
$3.4M
Investors
Questions about Tridek-One
Who invested in Tridek-One?
Tridek-One has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tridek-One raised?
Tridek-One has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tridek-One last raise money?
Tridek-One's most recent round on record is a Series A, in Nov 2018.
What does Tridek-One do?
Based in Paris, France, and founded in 2018, Tridek-One SAS is a biotechnology startup focused on the research and development of CD31 agonist molecules, intended for restoring the immune balance in patients suffering from auto-immune diseases.
Where is Tridek-One headquartered?
Tridek-One is headquartered in Paris, France.
Which VCs invest in companies like Tridek-One?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Tridek-One's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tridek-One? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.